FDA Authorizes First Robotic Blood Draw Device, Aletta, to Address Phlebotomist Shortage
The U.S. Food and Drug Administration (FDA) has authorized the Aletta, a groundbreaking standalone robotic device capable of drawing blood from a patient's arm without direct human intervention. This authorization marks a significant advancement in medical technology, particularly in response to a growing shortage of trained phlebotomists across the U.S. The Aletta is approved for use in adults within outpatient settings and requires oversight from a phlebotomy-trained supervisor, with one supervisor able to manage up to three devices simultaneously. The device autonomously performs all steps of the blood draw, from guiding the patient to position their arm, to locating a suitable vein using near-infrared light and Doppler ultrasound, applying a tourniquet, preparing the skin, inserting and disposing of the needle, changing collection tubes, and finally placing a bandage. Safety features include automatic needle detachment if a patient moves excessively and continuous disinfectant application during the ul... 
